Literature DB >> 1415457

Efficacy of fluid-air exchange for postvitrectomy diabetic vitreous hemorrhage.

D F Martin1, B W McCuen.   

Abstract

We reviewed the records of 33 fluid-air exchanges to assess the efficacy of fluid-air exchange in the management of recurrent vitreous cavity hemorrhage after vitrectomy for proliferative diabetic retinopathy. Fluid-air exchange alone was successful in clearing the vitreous cavity in ten of 20 eyes after a mean of 1.5 exchanges per eye. Repeat vitrectomy was required in the remaining ten eyes and anterior hyaloidal fibrovascular proliferation was frequently found. Hemorrhages that occurred in the late postoperative period (more than nine months) appeared more likely to be successfully treated with fluid-air exchange alone. Failure of the initial fluid-air exchange to induce clearing immediately after the procedure appeared to be associated with subsequent exchange failures and need for surgical intervention. Complications from the exchange procedure were infrequent with the development of peripheral retinal detachment in one eye. Our current recommendation for nonclearing recurrent postvitrectomy diabetic vitreous hemorrhage is to perform a fluid-air exchange, provided no other high-risk characteristics are present. If clearing occurs in the immediate postexchange period but rebleeding occurs at a later period, we recommend a second fluid-air exchange. If clearing does not occur in the immediate postexchange period, we recommend proceeding directly to revision of vitrectomy.

Entities:  

Mesh:

Year:  1992        PMID: 1415457     DOI: 10.1016/s0002-9394(14)71858-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Management of postvitrectomy diabetic vitreous hemorrhage with volume homeostatic fluid-fluid exchanger.

Authors:  Wen-Chuan Wu; Jen-Yu Chen; Ya-Chi Chen; Yo-Chen Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-07       Impact factor: 3.117

2.  Long-term results of vitreous surgery for proliferative diabetic retinopathy.

Authors:  P Sima; T Zoran
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

3.  Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).

Authors:  Wayne R Lo; Stephen J Kim; Thomas M Aaberg; Christopher Bergstrom; Sunil K Srivastava; Jiong Yan; Daniel F Martin; G Baker Hubbard
Journal:  Retina       Date:  2009 Jul-Aug       Impact factor: 4.256

4.  Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).

Authors:  Xu Liang; Yue Zhang; Jia-Xing Wang; Li-Fei Wang; Wan-Rong Huang; Xin Tang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

5.  Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.

Authors:  Baojie Hou; Yifei Huang; Qun Wang; Jie Zhao; Qing Xu; Cui Han
Journal:  BMC Ophthalmol       Date:  2021-03-09       Impact factor: 2.209

6.  The efficacy of fluid-gas exchange for the treatment of postvitrectomy retinal detachment.

Authors:  Ji Hye Jang; Yu Cheol Kim; Kwang Soo Kim
Journal:  Korean J Ophthalmol       Date:  2009-12-04

Review 7.  Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Authors:  Jonathan M Smith; David H W Steel
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07

8.  Efficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage.

Authors:  Sun Young Lee; Hee Gyung Lee; Hye-won Chung; Young Hee Yoon; June-Gone Kim
Journal:  Korean J Ophthalmol       Date:  2007-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.